Skip to main navigation
Skip to search
Skip to main content
Maastricht University Home
Support & FAQ
Home
Researchers
Publications
Activities
Press/Media
Prizes
Organisations
Datasets
Projects
Search by expertise, name or affiliation
Kynurenines: from the perspective of major psychiatric disorders
Aye-Mu Myint
*
*
Corresponding author for this work
Psychiatrie & Neuropsychologie
MHeNs - Mental Health and Neuroscience Research Institute
Research output
:
Contribution to journal
›
Article
›
Academic
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Kynurenines: from the perspective of major psychiatric disorders'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Psychiatric Disorders
100%
Kynurenine
100%
Major Psychiatric Disorders
100%
Pathophysiological Mechanisms
50%
Metabolism
50%
Cerebrospinal Fluid
50%
Therapeutic Potential
50%
Receptor Agonist
50%
Brain Regions
50%
Antidepressants
50%
Kynurenine Pathway
50%
Schizophrenia
50%
Clinical Improvement
50%
Drug-induced
50%
N-methyl-D-aspartate Receptor (NMDAR)
50%
Antipsychotics
50%
Inflammatory Mediators
50%
Inflammatory State
50%
Future Therapeutics
50%
Neurotoxic Effects
50%
Quinolinic Acid
50%
Neurochemicals
50%
Kynurenic Acid
50%
Mood Stabilizers
50%
Interferon-α (IFN-α)
50%
Manic Depression
50%
Neuroprotective Effect
50%
Tryptophan Breakdown
50%
Unipolar Depression
50%
Excitotoxic
50%
Neurochemical Changes
50%
Metabolic Imbalance
50%
Kynurenine Metabolites
50%
Neuropsychiatric Adverse Events
50%
Kynurenine Metabolism
50%
INIS
kynurenine
100%
metabolism
40%
inflammation
40%
patients
20%
drugs
20%
receptors
20%
side effects
20%
brain
20%
reviews
20%
animals
20%
biological markers
20%
tryptophan
20%
metabolites
20%
cerebrospinal fluid
20%
interactions
20%
plasma
20%
breakdown
20%
antidepressants
20%
interferon
20%
kynurenic acid
20%
Neuroscience
Kynurenine
100%
Metabolic Pathway
40%
Antidepressant
20%
Major Depressive Disorder
20%
Brain Areas
20%
Antipsychotic
20%
Tryptophan
20%
Bipolar Disorder
20%
Aspartic Acid
20%
Receptor Agonists
20%
Neuroprotective Agent
20%
Interferon
20%
Kynurenic Acid
20%
Quinolinic Acid
20%
Mood Stabilizer
20%
Bipolar Depression
20%
Blood Plasma
20%
Pharmacology, Toxicology and Pharmaceutical Science
Kynurenine
100%
Antipsychotic
20%
Side Effect
20%
Biological Marker
20%
Tryptophan
20%
Antidepressant
20%
Bipolar Disorder
20%
Major Depression
20%
Aspartic Acid
20%
Receptor Agonist
20%
Interferon
20%
Kynurenic Acid
20%
Neuroprotective Agent
20%
Quinolinic Acid
20%
Mood Stabilizer
20%